Search
for
Sort by
Research 211–240 of 1000+
- Common urologic diseases in older men and their treatment: how they impact fertility
- This Month in Adult Urology
- Therapeutic Strategies to Target the Androgen Receptor
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Medicine Update
- Chaperones as thermodynamic sensors
- Flutamide
- Targeting receptor–regulator interactions
- Comparative Outcomes of Cutaneous Vesicostomy Versus Cystoscopic Valve Ablation in the Initial Management of Posterior Urethral Valves
- Finasteride en de preventie van prostaatcarcinoom
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향
- Chemoprävention des Prostatakarzinoms - Ein Plädoyer
- Abstract ED05-04: Presurgical models to effectively screen preventive agents
- Additive in vivo growth-inhibitory effects of flutamide and finasteride on androgen-sensitive Shionogi 115 carcinoma
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- A Slippery Preventive Slope
- Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility
- 테스토스테론으로 유도된 전립선 비대증에 대한 Sapium rotundifolium Hemsl. 추출물의 효과
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Hormone Blocking Anticancer Drugs
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Clinical applications of antiandrogens
- 309 DOES VARIATION IN EITHER AGE AT START OF THERAPY OR DURATION OF THERAPY MAKE CHEMOPREVENTION WITH FINASTERIDE COST-EFFECTIVE?
- Male androgenetic alopecia (Part II)
- Arzneimitteltherapie der Alopezien
- Anti-Androgenic Potential of Plant Extracts: Molecular Mechanisms, Synergistic Effects, and Nutritional Interventions
- Metformin and Malignant Tumors: Not Over the Hill